Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

Surface-engineered polyelectrolyte multilayer capsules: synthetic vaccines mimicking microbial structure and function.

De Geest BG, Willart MA, Lambrecht BN, Pollard C, Vervaet C, Remon JP, Grooten J, De Koker S.

Angew Chem Int Ed Engl. 2012 Apr 16;51(16):3862-6. doi: 10.1002/anie.201200048. Epub 2012 Mar 12.

PMID:
22411781
[PubMed - indexed for MEDLINE]
2.

A comparative study of the antigen-specific immune response induced by co-delivery of CpG ODN and antigen using fusion molecules or biodegradable microparticles.

Zhang XQ, Dahle CE, Weiner GJ, Salem AK.

J Pharm Sci. 2007 Dec;96(12):3283-92.

PMID:
17497736
[PubMed - indexed for MEDLINE]
3.

Efficacy of intracellular activated promoters for generation of Salmonella-based vaccines.

Xu X, Husseiny MI, Goldwich A, Hensel M.

Infect Immun. 2010 Nov;78(11):4828-38. doi: 10.1128/IAI.00298-10. Epub 2010 Aug 23.

PMID:
20732994
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

From the 2-dimensional unstable polyelectrolyte multilayer to the 3-dimensional stable dry polyelectrolyte capsules.

Li X, Zhang J, Hu Q, Li X.

J Colloid Interface Sci. 2011 Nov 1;363(1):64-72. doi: 10.1016/j.jcis.2011.07.034. Epub 2011 Jul 23.

PMID:
21821261
[PubMed - indexed for MEDLINE]
5.

Polyelectrolyte LbL microcapsules versus PLGA microparticles for immunization with a protein antigen.

De Temmerman ML, Rejman J, Vandenbroucke RE, De Koker S, Libert C, Grooten J, Demeester J, Gander B, De Smedt SC.

J Control Release. 2012 Mar 10;158(2):233-9. doi: 10.1016/j.jconrel.2011.10.029. Epub 2011 Oct 29.

PMID:
22063002
[PubMed - indexed for MEDLINE]
7.

Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.

Grossmann C, Tenbusch M, Nchinda G, Temchura V, Nabi G, Stone GW, Kornbluth RS, Uberla K.

BMC Immunol. 2009 Aug 3;10:43. doi: 10.1186/1471-2172-10-43.

PMID:
19650904
[PubMed - indexed for MEDLINE]
Free PMC Article
8.
9.

B subunit of Shiga toxin-based vaccines synergize with alpha-galactosylceramide to break tolerance against self antigen and elicit antiviral immunity.

Adotevi O, Vingert B, Freyburger L, Shrikant P, Lone YC, Quintin-Colonna F, Haicheur N, Amessou M, Herbelin A, Langlade-Demoyen P, Fridman WH, Lemonnier F, Johannes L, Tartour E.

J Immunol. 2007 Sep 1;179(5):3371-9.

PMID:
17709554
[PubMed - indexed for MEDLINE]
Free Article
10.

Synthetic nanoparticle vaccines produced by layer-by-layer assembly of artificial biofilms induce potent protective T-cell and antibody responses in vivo.

Powell TJ, Palath N, DeRome ME, Tang J, Jacobs A, Boyd JG.

Vaccine. 2011 Jan 10;29(3):558-69. doi: 10.1016/j.vaccine.2010.10.001. Epub 2010 Oct 15.

PMID:
20951665
[PubMed - indexed for MEDLINE]
11.

Polyelectrolyte microcapsules as antigen delivery vehicles to dendritic cells: uptake, processing, and cross-presentation of encapsulated antigens.

De Koker S, De Geest BG, Singh SK, De Rycke R, Naessens T, Van Kooyk Y, Demeester J, De Smedt SC, Grooten J.

Angew Chem Int Ed Engl. 2009;48(45):8485-9. doi: 10.1002/anie.200903769. No abstract available.

PMID:
19810070
[PubMed - indexed for MEDLINE]
12.

Versatile RHDV virus-like particles: incorporation of antigens by genetic modification and chemical conjugation.

Peacey M, Wilson S, Baird MA, Ward VK.

Biotechnol Bioeng. 2007 Dec 1;98(5):968-77.

PMID:
17546687
[PubMed - indexed for MEDLINE]
13.

Biodegradable polyelectrolyte microcapsules: antigen delivery tools with Th17 skewing activity after pulmonary delivery.

De Koker S, Naessens T, De Geest BG, Bogaert P, Demeester J, De Smedt S, Grooten J.

J Immunol. 2010 Jan 1;184(1):203-11. doi: 10.4049/jimmunol.0803591. Epub 2009 Nov 30.

PMID:
19949090
[PubMed - indexed for MEDLINE]
Free Article
14.

Recrystallization of bacterial S-layers on flat polyelectrolyte surfaces and hollow polyelectrolyte capsules.

Toca-Herrera JL, Krastev R, Bosio V, Küpcü S, Pum D, Fery A, Sára M, Sleytr UB.

Small. 2005 Mar;1(3):339-48.

PMID:
17193454
[PubMed - indexed for MEDLINE]
15.

Role of interferon-gamma during CpG oligodeoxynucleotide-adjuvanted immunization with recombinant proteins.

Rosa DS, Bastos KR, Bargieri DY, Tzelepis F, Nomizo A, Russo M, Soares IS, Rodrigues MM.

Vaccine. 2007 Aug 10;25(32):6007-17. Epub 2007 Jun 6.

PMID:
17629370
[PubMed - indexed for MEDLINE]
16.

Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.

San Román B, Irache JM, Gómez S, Tsapis N, Gamazo C, Espuelas MS.

Eur J Pharm Biopharm. 2008 Sep;70(1):98-108. doi: 10.1016/j.ejpb.2008.03.015. Epub 2008 Mar 31.

PMID:
18501572
[PubMed - indexed for MEDLINE]
17.

Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.

Galea-Lauri J, Wells JW, Darling D, Harrison P, Farzaneh F.

Cancer Immunol Immunother. 2004 Nov;53(11):963-77. Epub 2004 May 14.

PMID:
15146294
[PubMed - indexed for MEDLINE]
18.

Salt softening of polyelectrolyte multilayer microcapsules.

Lebedeva OV, Kim BS, Vasilev K, Vinogradova OI.

J Colloid Interface Sci. 2005 Apr 15;284(2):455-62.

PMID:
15780282
[PubMed - indexed for MEDLINE]
19.

Novel roles of CpG oligodeoxynucleotides as a leader for the sampling and presentation of CpG-tagged antigen by dendritic cells.

Shirota H, Sano K, Hirasawa N, Terui T, Ohuchi K, Hattori T, Shirato K, Tamura G.

J Immunol. 2001 Jul 1;167(1):66-74.

PMID:
11418633
[PubMed - indexed for MEDLINE]
Free Article
20.

Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response.

Fischer S, Schlosser E, Mueller M, Csaba N, Merkle HP, Groettrup M, Gander B.

J Drug Target. 2009 Sep;17(8):652-61. doi: 10.1080/10611860903119656.

PMID:
19622019
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk